Researchers Design A Viral Vector To Treat A Genetic Form Of Blindness
Researchers at Ohio State University Medical Center and Nationwide Children's Hospital have developed a viral vector designed to deliver a gene into the eyes of people born with an inherited, progressive form of blindness that affects mainly males.
DARA Announces Positive Results From Phase 1b Clinical Study For The Treatment Of Type 2 Diabetes
DARA BioSciences, Inc. (NASDAQ: DARA), announces the positive results from a successfully completed Phase 1b clinical study for DB959, its peroxisome proliferator activated receptor (PPAR)-delta/gamma agonist, a non-TZD oral drug in development for the treatment of type 2 diabetes. This study's main objectives were to
Participation Rates In HIV Vaccine Trials Possibly Affected By Misconceptions
On December 1st, World AIDS Day 2011 will be observed in many countries around the globe. The theme of this year's World AIDS Day is "Getting to Zero" specifically, zero new HIV infections, zero discrimination and zero AIDS-related deaths.
XML Feeds
